{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:34:58Z","timestamp":1789824898031,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005039","name":"Leiden University Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bbmt.2014.10.012","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T03:04:51Z","timestamp":1413428691000},"page":"293-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["The Effect of Cidofovir on Adenovirus Plasma DNA Levels in Stem Cell Transplantation Recipients without T Cell Reconstitution"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3697-9316","authenticated-orcid":false,"given":"Gertjan","family":"Lugthart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes A.","family":"Oomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia M.","family":"Jol-van der Zijde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorine","family":"Bresters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter J.W.","family":"Kollen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans J.","family":"Smiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementien L.","family":"Vermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert G.M.","family":"Bredius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco W.","family":"Schilham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.D.","family":"van Tol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan C.","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2014.10.012_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/rmv.589","article-title":"Clinical features and treatment of adenovirus infections","volume":"18","author":"Lenaerts","year":"2008","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.bbmt.2014.10.012_bib2","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood-2004-02-0646","article-title":"Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells","volume":"104","author":"Leen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.10.012_bib3","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3324\/haematol.2010.022947","article-title":"Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection","volume":"95","author":"Zandvliet","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2014.10.012_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/427513","article-title":"Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients","volume":"191","author":"Heemskerk","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib5","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/313514","article-title":"Adenovirus infections in hematopoietic stem cell transplant recipients","volume":"29","author":"Howard","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib6","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/sj.bmt.1704852","article-title":"Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity","volume":"35","author":"van Tol","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.10.012_bib7","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","article-title":"Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery","volume":"100","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.10.012_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1473-3099(03)00515-2","article-title":"Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients","volume":"3","author":"Walls","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1086\/341770","article-title":"High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation","volume":"35","author":"Schilham","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.10.012_bib11","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1086\/420817","article-title":"Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection","volume":"38","author":"Lankester","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/135965350901400110","article-title":"Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone","volume":"14","author":"Morfin","year":"2009","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bbmt.2014.10.012_bib13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/AAC.49.3.1010-1016.2005","article-title":"Antiadenovirus activities of several classes of nucleoside and nucleotide analogues","volume":"49","author":"Naesens","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2014.10.012_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/135965350501000204","article-title":"In\u00a0vitro susceptibility of adenovirus to antiviral drugs is species-dependent","volume":"10","author":"Morfin","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bbmt.2014.10.012_bib15","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1086\/498151","article-title":"Clinical and in\u00a0vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients","volume":"41","author":"Muller","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib16","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.11279","article-title":"Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome","volume":"92","author":"Robin","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2014.10.012_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1399-3062.2006.00184.x","article-title":"Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir","volume":"9","author":"Symeonidis","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/bbmt.2001.v7.pm11529489","article-title":"Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation","volume":"7","author":"Hoffman","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.10.012_bib19","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/01.tp.0000209195.95115.8e","article-title":"Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients","volume":"81","author":"Yusuf","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2014.10.012_bib20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bbmt.2013.11.009","article-title":"Patient, virus and treatment-related risk factors in pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring program","volume":"20","author":"Mynarek","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.10.012_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bmt.1703798","article-title":"Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation","volume":"31","author":"Ljungman","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.10.012_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1399-3062.2009.00391.x","article-title":"Safety and tolerability of cidofovir in high-risk pediatric patients","volume":"11","author":"Bhadri","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib23","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/infdis\/171.4.788","article-title":"(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I\/II study of a novel antiviral nucleotide analogue","volume":"171","author":"Lalezari","year":"1995","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1086\/520475","article-title":"Cidofovir-induced end-stage renal failure","volume":"29","author":"Vandercam","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib25","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/JCM.43.4.1738-1744.2005","article-title":"Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients","volume":"43","author":"Claas","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.bbmt.2014.10.012_bib26","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1182\/blood.V79.12.3239.bloodjournal79123239","article-title":"CD16- CD56+ natural killer cells after bone marrow transplantation","volume":"79","author":"Jacobs","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.10.012_bib27","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","article-title":"Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation","volume":"97","author":"Storek","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.10.012_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-032712-100001","article-title":"Control of human viral infections by natural killer cells","volume":"31","author":"Jost","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bbmt.2014.10.012_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2276","article-title":"Evolutionary struggles between NK cells and viruses","volume":"8","author":"Lanier","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2014.10.012_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines","volume":"17","author":"Biron","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bbmt.2014.10.012_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molimm.2012.02.119","article-title":"Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling","volume":"51","author":"Pahl","year":"2012","journal-title":"Mol Immunol"},{"key":"10.1016\/j.bbmt.2014.10.012_bib32","first-page":"5260","article-title":"Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection","volume":"62","author":"Miller","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2014.10.012_bib33","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.4049\/jimmunol.149.7.2372","article-title":"IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing","volume":"149","author":"Routes","year":"1992","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2014.10.012_bib34","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1086\/429235","article-title":"Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary?","volume":"40","author":"Walls","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/319352","article-title":"Adenovirus infections in adult recipients of blood and marrow transplants","volume":"32","author":"La Rosa","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib36","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood.V97.5.1232","article-title":"Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation","volume":"97","author":"Cwynarski","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.10.012_bib37","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1182\/blood-2002-05-1387","article-title":"Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells","volume":"100","author":"Ozdemir","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.10.012_bib38","first-page":"2774","article-title":"Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir","volume":"37","author":"Gordon","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.bbmt.2014.10.012_bib39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbmt.2011.09.007","article-title":"Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients","volume":"18","author":"Florescu","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.10.012_bib40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jcv.2005.10.017","article-title":"Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patients","volume":"35","author":"Ljungman","year":"2006","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.bbmt.2014.10.012_bib41","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/503838","article-title":"Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitution","volume":"42","author":"Annels","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.10.012_bib42","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1097\/TP.0b013e318224f263","article-title":"Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience","volume":"92","author":"Solano","year":"2011","journal-title":"Transplantation"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114006375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114006375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:48:38Z","timestamp":1761058118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879114006375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1083879114006375"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.10.012","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Cidofovir on Adenovirus Plasma DNA Levels in Stem Cell Transplantation Recipients without T Cell Reconstitution","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}